Haiying Que

No. 17, Block 3, Southern Renmin Road
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Mucosal immunity and vaccination strategies: current insights and future perspectives.

Mucosal immunity and vaccination strategies: current insights and future perspectives.

Journal: Molecular biomedicine

Published: May 06, 2025

CD94/NKG2A-Qa-1b axis as a key modulator of vaccine responsiveness in aging populations.

CD94/NKG2A-Qa-1b axis as a key modulator of vaccine responsiveness in aging populations.

Journal: Cell reports

Published: April 24, 2025

Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy.

Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy.

Journal: Molecular cancer

Published: January 19, 2025

Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targets.

Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targets.

Journal: Nature immunology

Published: January 07, 2025

Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer.

Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer.

Journal: Journal of hematology & oncology

Published: January 02, 2025

mRNA vaccines as cancer therapies.

mRNA vaccines as cancer therapies.

Journal: Chinese medical journal

Published: October 14, 2024

Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes.

Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes.

Journal: Acta pharmaceutica Sinica. B

Published: February 23, 2024

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.

Journal: Nature biomedical engineering

Published: February 11, 2024

A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.

A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.

Journal: MedComm

Published: November 23, 2023

Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform.

Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform.

Journal: Cellular & molecular immunology

Published: August 21, 2023

SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.

SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.

Journal: The Journal of clinical investigation

Published: July 28, 2023

Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses.

Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses.

Journal: Genes & diseases

Published: April 13, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026